Astria Therapeutics, Inc. Revenue
Astria Therapeutics, Inc. reported Revenue of $706.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-11-12
- Astria Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $706.00K.
- Astria Therapeutics, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-09-30 was $0.00.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month |
|---|---|---|
| 2025-09-30 | $706.00K 10-Q · filed 2025-11-12 | $706.00K 10-Q · filed 2025-11-12 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 |